Teva's Barr Labs settles Cipro antitrust case for $225 million

(Reuters) - Teva Pharmaceutical Industries Ltd's Barr Laboratories Inc has reached a $225 million settlement in an antitrust class action that accused the drugmaker of keeping a generic version of Bayer AG's antibiotic Cipro off the market, court documents showed.